XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.25.1

Earnings (Loss) per Share | 3 Months Ended
--- | ---
May 03, 2025
Earnings Per Share [Abstract] |
Earnings (Loss) per Share | Earnings (Loss) per Share The computation of basic and diluted net earnings (loss) per common share attributable to common stockholders is (in thousands, except per share data):
| Three Months Ended |  |
| May 3, 2025 |  | May 4, 2024 |  |  |  |
Net earnings (loss) attributable to Guess?, Inc. | $ | (32,928) |  |  | $ | 13,022 |  |  |  |  |
Less net earnings attributable to nonvested restricted stockholders | 212 |  |  | 318 |  |  |  |  |
Net earnings (loss) attributable to common stockholders | (33,140) |  |  | 12,704 |  |  |  |  |
Remove expenses related to the convertible senior notes 1 | — |  |  | 122 |  |  |  |  |
Net earnings (loss) attributable to common stockholders used in diluted computations | $ | (33,140) |  |  | $ | 12,826 |  |  |  |  |
Weighted average common shares used in basic computations | 51,375 |  |  | 52,908 |  |  |  |  |
Effect of dilutive securities: |  |  |  |  |  |  |
Stock options and restricted stock units | — |  |  | 1,538 |  |  |  |  |
Convertible senior notes | — |  |  | 1,092 |  |  |  |  |
Weighted average common shares used in diluted computations | 51,375 |  |  | 55,538 |  |  |  |  |
Net earnings (loss) per common share attributable to common stockholders:
Basic | $ | (0.65) |  |  | $ | 0.24 |  |  |  |  |
Diluted | $ | (0.65) |  |  | $ | 0.23 |  |  |  |  |
______________________________________________________________________ Notes: 1 Expenses related to the convertible senior notes include interest expense, loss on extinguishment of debt and loss on fair value remeasurement for embedded derivative, as applicable, net of associated income tax effect. Certain potentially dilutive common stock, including certain equity awards granted that were outstanding as well as shares issuable under convertible senior notes, are not included in the computation of diluted weighted average common shares and potential common shares outstanding if their effect would have been antidilutive. Antidilutive shares excluded from the computation of diluted weighted average common shares and potential common shares outstanding are:
| Three Months Ended |  |
| May 3, 2025 |  | May 4, 2024 |  |  |  |
Stock options and restricted stock units 1 | 2,953,772 |  |  | 149,626 |  |  |  |  |
Convertible senior notes (as converted) | 15,938,865 |  |  | 14,741,039 |  |  |  |  |
Total | 18,892,637 |  |  | 14,890,665 |  |  |  |  |
______________________________________________________________________ Notes: 1 During the three months ended May 3, 2025, 438,499 potentially dilutive shares were excluded given the Company’s net loss and 2,515,273 potentially dilutive shares were excluded because the assumed proceeds resulted in these awards being antidilutive. During the three months ended May 4, 2024, potentially dilutive shares were excluded because the assumed proceeds resulted in these awards being antidilutive. Additionally, the Company excluded 517,704 and 300,000 nonvested stock units which were subject to the achievement of performance-based or market-based vesting conditions from the computation of diluted weighted average common shares and potential common shares outstanding because these conditions were not achieved as of May 3, 2025 and May 4, 2024, respectively. There were no warrants related to the 2.00% convertible senior notes due April 2024 (the “2024 Notes”) outstanding as of May 3, 2025. Warrants related to the 2024 Notes to purchase approximately 1.3 million shares of the Company’s common shares at an adjusted strike price of $41.45 per share were outstanding as of May 4, 2024. Warrants related to the 3.75% convertible senior notes due April 2028 (the “2028 Notes”, and together with the 2024 Notes, the “Notes”) to purchase approximately 16.0 million and 15.7 million shares of the Company’s common shares at adjusted strike prices of $37.13 and $37.89 per share were outstanding as of May 3, 2025 and May 4, 2024, respectively. During the three months ended May 3, 2025 and May 4, 2024, these warrants were excluded from the computation of diluted net earnings (loss) per share since the warrants’ strike prices were greater than the average market price of the Company’s common stock. See Note 11 - Convertible Senior Notes and Related Transactions for more information regarding the Notes and related hedge transactions.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration